Arcutis Biotherapeutics Earnings
NASDAQ: ARQTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Oct 27, 2026
Fiscal period
Sep/2026
EPS estimate
$0.17
Arcutis Biotherapeutics earnings summary
Arcutis Biotherapeutics is scheduled to report Sep/2026 earnings on Oct 27, 2026, with analysts expecting EPS of $0.17. In its most recent report on Aug 5, 2026 (Q2 2026), ARQT posted EPS of $0.11. Revenue for the quarter was $129.9 million.
Across the last 16 reports, ARQT shares moved an average of 9.2% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
ARQT earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $0.11 | — | +3.6% |
| May 6, 2026 | — | $-0.09 | — | +0.7% |
| Feb 25, 2026 | — | $0.14 | — | -11.0% |
| Oct 28, 2025 | — | $0.06 | — | -4.3% |
| Aug 6, 2025 | — | $-0.13 | — | +14.4% |
| May 6, 2025 | — | $-0.20 | — | +4.3% |
| Feb 25, 2025 | — | $-0.09 | — | +7.5% |
| Nov 6, 2024 | — | $-0.33 | — | -14.4% |
| Aug 14, 2024 | — | $-0.42 | — | +15.8% |
| May 14, 2024 | — | $-0.32 | — | -0.4% |
| Feb 27, 2024 | — | $-0.58 | — | -5.3% |
| Nov 3, 2023 | — | $-0.73 | — | -21.9% |
| Aug 8, 2023 | — | $-1.16 | — | -12.7% |
| May 9, 2023 | — | $-1.31 | — | -6.1% |
| Feb 28, 2023 | — | $-1.19 | — | -22.3% |
| Nov 8, 2022 | — | $-1.89 | — | -1.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.